Securities Lawyer 101 Blog On May 16, 2-014, the Securities and Exchange Commission (“Commission”) announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange Act”), of trading in the securities of FusionPharm, Inc. (“FusionPharm”) of Denver, Colorado, at 9:30 a.m. EDT on May 16, 2014, and terminating at 11:59 p.m. EDT on May... Read More
http://www.securitieslawyer101.com/fusion-pharm/
No comments:
Post a Comment